Diagnostics News and Research

RSS

RainDance Technologies announces closing of $20M Series E financing round

RainDance Technologies, Inc., the Digital Biology Company, today announced the closing of a $20 million Series E financing round. The company also announced that Myriad Genetics, Inc. has joined as a new strategic equity investor.

29 Apr 2013

Opsona raises €33M in oversubscribed financing round

Opsona Therapeutics Limited, the innate immune drug development company, today announced that it has raised €33 million (US $ 43 million) in an oversubscribed Series C financing.

29 Apr 2013

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Oxford BioTherapeutics and Boehringer Ingelheim today announce a new alliance focused on the discovery of novel cancer antibody targets that OBT will identify with the help of its OGAP® discovery platform.

29 Apr 2013

Biological imaging technologies create a new way to learn about cells

Researchers have married two biological imaging technologies, creating a new way to learn how good cells go bad. "Let's say you have a large population of cells," said Corey Neu, an assistant professor in Purdue University's Weldon School of Biomedical Engineering.

26 Apr 2013

Latin America facing an alarming increase in cancer rates

Latin America is facing an alarming increase in cancer rates, and unless urgent action is taken to prevent cancers, improve health-care systems and facilities, access to vital medical care, and treatment of poor people, the region threatens to be overwhelmed by the burgeoning epidemic, say the authors of a major new report on cancer control in the region, published in The Lancet Oncology, and launched at the Latin American Cooperative Oncology Group (LACOG) 2013 conference in São Paulo, Brazil.

26 Apr 2013

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.

From Thermo Fisher Scientific Inc. 26 Apr 2013

New Thermo Scientific Aegis5-14 film for cell culture and bioprocessing applications

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Aegis5-14 Film, the company's new advanced single-use film that is ideal for the most demanding cell culture and bioprocessing applications in drug development and biomanufacturing.

From Thermo Fisher Scientific Inc. 26 Apr 2013

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.

26 Apr 2013

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Immudex has entered into a strategic agreement with the US Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute, and the European Association for Cancer Immunotherapy (CIMT), under which Immudex will provide MHC-peptide multimer and Elispot proficiency panel services worldwide.

26 Apr 2013

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical trials of the medication within the next few months.

26 Apr 2013

High-energy proton beam therapy offers potential treatment option for eye cancer

Particle beams - from low energy beams with exotic ions through to extremely high energy light sources - are revolutionising the way we view the world and creating potential for new industries, but the instrumentation for controlling the beams is still in its infancy.

26 Apr 2013

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.

25 Apr 2013

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Devex features a sponsored interview with Dennis Broun, executive director of UNITAID, which uses innovative financing and "its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income countries."

25 Apr 2013

Higher TMAO blood levels linked to increased risk of heart disease

A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal of Medicine.

25 Apr 2013

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Nanogels are synthetic particles that can be used for drug delivery. They are approximately 100 nm to 200 nm in diameter, and are made from safe, biocompatible materials: a gel-like interior and a lipid exterior.

24 Apr 2013

Study identifies gene variants associated with histological features of NAFLD

More patients could be diagnosed earlier with non-alcoholic fatty liver disease after a cohort study presented at the International Liver Congress 2013 identified variants within four genes significantly associated with the histological features of the disease.

24 Apr 2013

Thermo Scientific Scientific launches HyPerforma SUM DS 300 system for multiple uses

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Mixer DS 300 system, an innovative, cost-effective single-use mixer ideal for pilot-scale liquid preparations for vaccine and biologic manufacturing.

From Thermo Fisher Scientific Inc. 24 Apr 2013

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

Rheumatoid arthritis (RA) is an autoimmune disorder that can cause debilitating joint damage. In cases of RA, the immune system attacks the body’s own tissues, especially the membranes that line the joints. As a result, fluid builds up in the joints, causing pain and systemic inflammation, leading to joint destruction if untreated.

From Quest Diagnostics 23 Apr 2013

RUSM students to perform clinical training at Vanguard MacNeal Hospital

Ross University School of Medicine announced an agreement with Vanguard MacNeal Hospital in Berwyn, Ill. which enables RUSM students to perform clinical training in the Chicago-area teaching hospital.

23 Apr 2013

Theradiag obtains CE mark for proprietary anti-CCP IVD kit in rheumatoid arthritis

Theradiag, a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for its proprietary anti-CCP in vitro diagnostic kit in rheumatoid arthritis.

23 Apr 2013

Diagnostics News and Research

RainDance Technologies announces closing of $20M Series E financing round

Opsona raises €33M in oversubscribed financing round

Oxford BioTherapeutics, Boehringer Ingelheim team up to discover novel cancer antibody targets

Biological imaging technologies create a new way to learn about cells

Latin America facing an alarming increase in cancer rates

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

New Thermo Scientific Aegis5-14 film for cell culture and bioprocessing applications

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

High-energy proton beam therapy offers potential treatment option for eye cancer

Three steps to eliminating NTDs

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Higher TMAO blood levels linked to increased risk of heart disease

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Study identifies gene variants associated with histological features of NAFLD

Thermo Scientific Scientific launches HyPerforma SUM DS 300 system for multiple uses

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

RUSM students to perform clinical training at Vanguard MacNeal Hospital

Theradiag obtains CE mark for proprietary anti-CCP IVD kit in rheumatoid arthritis

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News